Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study
Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.12835
Full Text
Open PDFAbstract
Available in full text
Date
December 28, 2017
Authors
Publisher
Wiley